This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The 3rd edition of Pharma Live Expo & Summit will be held from April 17 to 19, 2025, at the Bombay Exhibition Centre, Mumbai. Visitors can explore pharmaceutical machinery, API and raw material suppliers, R&D and innovation centres, and healthcare consulting services.
Accretion Pharmaceuticals, an Ahmedabad-headquartered pharmaceuticalsmanufacturer, announced that its initial public offering (IPO) will open for subscription on Wednesday, May 14, 2025. The anchor portion will be opened on Tuesday, May 13, 2025, and the issue will conclude on Friday, May 16, 2025.
Will 2025 see a more vigilant government when it comes to violations by pharma companies, be it GMP slip ups or the Uniform Code of PharmaceuticalManufacturing Practices (UCPMP)? 2025 could thus be a pivotal year for course corrections for all stakeholders. VIVEKA ROYCHOWDHURY, Editor viveka.r@expressindia.com
Drawing from DCIs new 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers , we explore how pharmaceuticalmanufacturers structure their specialty pharmacy networksand how smaller, independent pharmacies have emerged as dominant players in exclusive networks. Today, we dive deeper. All rights reserved.
In a rapidly transforming pharmaceutical landscape, securing market access remains paramount. Looking ahead in 2025, several pivotal trends are set to redefine strategies for manufacturers and industry stakeholders. Source: Pharm Exec , January 31, 2025
Cipla has announced the appointment of Prabhakaran Balakrishnan Nair as its Global Chief Manufacturing Officer, effective July, 1, 2025. Nair will also join as a designated Senior Management Personnel. He is currently serving as the Chief of Quality at Ciplas Indore facility.
Pharmaceuticalmanufacturers are adopting advanced delivery platforms to improve drug efficacy and patient compliance, while scaling production for global distribution. From nanotechnology-based carriers to smart inhalation devices, these developments are reshaping how therapies are manufactured and administered. Reference 1.
senators sent letters to five telehealth companies that offer care through direct-to-consumer portals from pharmaceuticalmanufacturers Pfizer and Eli Lilly, interrogating their financial relationships , STAT tells us. Best of luck, and do keep in touch… A group of U.S. The U.S.
The report follows an inspection conducted from 27 January to 31 January 2025. This milestone underscores our commitment to upholding the highest standards of quality and compliance, solidifying our position as a leading pharmaceuticalmanufacturer.
billion in 340B savings is at risk, due to increasing limitations imposed by pharmaceuticalmanufacturers which could further strain the healthcare safety net and patient care services. As we enter 2025 Q2, the sad truth is that most 340B hospitals are struggling to protect their programs from further prescription-savings erosion.
Food and Drug Administration (USFDA) at its Active Pharmaceutical Ingredient (API) manufacturing facility in Alathur, Tamil Nadu. The inspection took place from 10 February 2025 to 18 February 2025 and resulted in seven minor observations, none related to data integrity.
This unique, new event will be held from March 17 to 19, 2025, at the Turnberry Resort and Spa in Miami. The Leadership Forum will be an executive gathering where drug channel leaders can network and discuss key issues and challenges facing the commercial healthcare system.
To address growing demand from the pharmaceutical industry, Asahi Kasei has launched a new division, Asahi Kasei Life Science, effective from 1 April 2025. The new structure is designed to unify its bioprocess businesses and streamline services offered to pharmaceutical partners across drug development and manufacturing.
Roquette Pharma Solutions' Christine Mya-San, global account manager, highlights the most significant pharma ingredients at play over the past year and discusses future ingredient innovation.
Based on the new cost estimates, pharmaceuticalmanufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.
Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCIs new live video webinar: Whats Next for Retail Pharmacy: Data, Debate, and Disruption This event will be broadcast live on: Friday, June 20, 2025 12:00 p.m. It is part of The Drug Channels 2025 Video Webinar Series.
I am pleased to announce that Drug Channels Institutes new 2025 Economic Report on U.S. Download a free 30-page report overview including key industry trends, What's New in this edition, the Table of Contents, and a List of Exhibits Read the press release: HMP Globals Drug Channels Institute Releases 2025 Economic Report on U.S.
The session focused on the manufacture of sterile drug products in line with the Revised Schedule M, bringing together key stakeholders and experts from across the pharmaceuticalmanufacturing ecosystem. Dr Birendra Singh, Senior President and Global Quality Head at Mankind Pharma, delivered the keynote address as Chief Guest.
Over half of the active pharmaceutical ingredients (API) for prescription medicines in the U.S. come from India and the European Union This blog is part of a series on the geographic concentration of pharmaceuticalmanufacturing. This blog focuses on the manufacturing of active pharmaceutical ingredients (API).
Tumble blenders deliver highly accurate and repeatable mixing of powders, granules and even low-viscosity slurries. In addition, this style blender enables complete discharge and easy cleaning.
Lidia Serina, PhD, head of Development Services at Simtra BioPharma Solutions, discusses the challenges with maintaining aseptic integrity in sterile injectable pharmaceuticalmanufacturing.
Heres a glimpse of what made the 2025 event such a success: Provocative panels with C-suite executives Off-the-record insights and open Q&A sessions No exhibit hall, no press, no distractionsjust substance 92% of 2025 attendees said they'd return! Join us at DCLF 2026 Invitations will begin going out in October 2025.
Contract research, development and manufacturing organisation (CRDMO) WuXi STA has broken ground on its new 190-acre pharmaceuticalmanufacturing campus in Middletown, Delaware, US. The WuXi STA Middletown facility is expected to begin operations in 2025.
Hyman, Phelps & McNamara PC, (HPM), which will mark its 45thAnniversary on March 17, 2025, is pleased to announce that it is increasing its directors, counsel, and associates as it starts the year. Richardson has been promoted to Director. Kalie is the quintessential HPM lawyer.
This exclusive event will be held from March 17 to 19, 2025, at the Turnberry Resort and Spa in Miami. Registered attendees include senior executives from pharmaceuticalmanufacturers, pharmacy benefit managers, health systems, physician practices, pharmacies, wholesalers, and more. drug channels. I hope you can join us!
The first industrial-scale pharmaceuticalmanufacturing facility for production of lead-212-based radioligand therapies has been inaugurated. The company hopes to produce this number tenfold by the end of 2030.
The construction projects will be finalised from the end of 2025 through to 2029. Novo Nordisk’s Denmark manufacturing facilities Currently, Novo Nordisk’s Kalundborg production facilities manufacture products for treating obesity and diabetes as well as several biopharmaceutical products, employing around 4,400 employees.
What are the top 3 trends that defined pharma manufacturing in India and globally in 2024? In 2024, the pharmaceuticalmanufacturing landscape underwent transformative changes, driven by technological innovations, regulatory adaptations, and evolving global demands.
Once operational in early 2025, the partnership will reduce emissions by an estimated 20,000 tonnes CO 2 equivalent (CO 2 e). Alongside this move, AstraZeneca’s investment in major energy efficiencies in its operations, brings the total of its financial commitment to net zero, to £100 million.
Over the next few years, there are virtually no aspects of pharmaceuticalmanufacturing processes that will not be changed by artificial intelligence (AI). Ensuring that AI systems meet regulatory requirements for pharmaceuticalmanufacturing is essential The complexity of AI models presents another challenge.
AbbVie , an international R&D biopharmaceutical enterprise has celebrated its 20th anniversary by investing in extensive renovations at its manufacturing site in Cork, Ireland. The €60 million expansion will open 70 new jobs in sterile manufacturing, quality control and engineering in 2025.
By incentivising eco-friendly production methods, we can position India as a pioneer in sustainable pharmaceuticalmanufacturing while meeting our environmental commitments. Increased support for export promotion will enable manufacturers in the plant-based industry to be more competitive globally.
This week, Im rerunning some popular posts while I prepare for Fridays Drug Channels Outlook 2025 live video webinar. As you reread the article below, note that some manufacturers have already announced wholesale acquisition cost (WAC) list price declines for 2025. Click here to see the original post.
A notable milestone was Moderna’s announcement in April that it had, following finalisation of a ten-year strategic partnership with the UK Government, commenced construction of its mRNA vaccine manufacturing technology centre.
300 crore, over the next two fiscal years (150 units each in 2024-25 and 2025-26). The intended beneficiaries are now specified as existing pharmaceuticalmanufacturing units with an average turnover of less than Rs. ” The revised scheme is expected to support 300 units, with a total outlay of Rs.
Pharmaceuticalmanufacturing Oligonucleotides Last month, the Centre for Process Innovation (CPI) announced a new Scotland-based manufacturing facility focusing on oligonucleotide therapeutics. According to CPI, the facility is set to be completed in late 2025.
With the opening of the new facility, “hundreds” of high-tech jobs will be established at the site by the end of 2025, according to BeiGene. The site in Hopewell features approximately 400,000 ft 2 for commercial-stage biologic pharmaceuticalmanufacturing capacity.
Implementing PAT in (bio)pharmaceuticalmanufacturing New sensors or larger equipment with more complex setups (software and hardware) require stringent procedures to become fully implemented in a good manufacturing practice (GMP) manufacturing facility. Boca Raton, FL: CRC Press. Salmenper M, Vilkko M.
The Parma site, as yet only nine months into construction, is due to become operational from 2024, with FDA, IFA, and EMA approvals due to be sought for 2025. In brief, the European plan for Chiesi is in-house drug development of biologicals and rare disease targeting.
NHC Submits Comments on FDA Draft Guidance on AI to Support Regulatory Decision-Making for Drugs/Biologics (PDF) April 7, 2025 Dockets Management Staff U.S. To maintain high product quality and regulatory compliance, the FDA should establish clear guidance for validating AI models used in pharmaceuticalmanufacturing.
If I’m a pharmacy operator, what do I actually need to do to make sure that I don’t get a fine in 2025 for failure to comply with DSCSA? I’ve now complained about companies and entities with tens of thousands of employees and the failures of their respective bureaucracies long enough.
CDMO Live is set to take place on 7-8 May 2025 at Rotterdam’s World Trade Center, bringing together key decision-makers in pharmaceutical outsourcing. The demand for outsourcing in pharmaceuticalmanufacturing has grown significantly, with nine out of ten biotechnology companies now depending on contract partners for production.
billion by 2025. They're signing up for training and asking questions about the journey of prescription drugs from pharmaceuticalmanufacturers to their employees’ medicine cabinets. The result? Americans’ overall spending on prescription drugs grew to $335 billion in 2018 and is projected to reach $511.1
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content